These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17531251)

  • 1. Bepridil produces prominent bradycardia-dependent QT prolongation in patients with structural heart disease.
    Sadanaga T; Ogawa S
    J Electrocardiol; 2007; 40(5):426-31. PubMed ID: 17531251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carvedilol is effective and safe in combination with bepridil for persistent atrial fibrillation and decreases the QT prolongation induced by bepridil therapy.
    Kawamura M; Munetsugu Y; Tanno K; Kobayashi Y
    J Cardiovasc Pharmacol; 2013 Jan; 61(1):77-82. PubMed ID: 23107870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proarrhythmic potential of reverse use-dependent drugs.
    Gussak I; Litwin J; Morganroth J
    J Electrocardiol; 2007; 40(5):432-3. PubMed ID: 17531256
    [No Abstract]   [Full Text] [Related]  

  • 4. Frequency and prognostic significance of QT prolongation in chronic renal failure patients.
    Voiculescu M; Ionescu C; Ismail G
    Rom J Intern Med; 2006; 44(4):407-17. PubMed ID: 18386617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bepridil: importance of serum level in treatment surveillance].
    Viallon A; Laporte-Simitsidis S; Pouzet V; Venet C; Tardy B; Zéni F; Bertrand JC
    Presse Med; 2000 Apr; 29(12):645-7. PubMed ID: 10780196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen-induced QT interval prolongation.
    Slovacek L; Ansorgova V; Macingova Z; Haman L; Petera J
    J Clin Pharm Ther; 2008 Aug; 33(4):453-5. PubMed ID: 18613864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beat-to-beat variability of QT intervals is increased in patients with drug-induced long-QT syndrome: a case control pilot study.
    Hinterseer M; Thomsen MB; Beckmann BM; Pfeufer A; Schimpf R; Wichmann HE; Steinbeck G; Vos MA; Kaab S
    Eur Heart J; 2008 Jan; 29(2):185-90. PubMed ID: 18156612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QT interval prolongation and decreased heart rates after intravenous bolus oxytocin injection in male and female conscious rabbits.
    Uzun M; Yapar K; Uzlu E; Citil M; Erdogan HM
    Gen Physiol Biophys; 2007 Sep; 26(3):168-72. PubMed ID: 18063843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of increased short-term variability of QT interval to congenital long-QT syndrome.
    Hinterseer M; Beckmann BM; Thomsen MB; Pfeufer A; Dalla Pozza R; Loeff M; Netz H; Steinbeck G; Vos MA; Kääb S
    Am J Cardiol; 2009 May; 103(9):1244-8. PubMed ID: 19406266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late potentials in a bradycardia-dependent long QT syndrome associated with sudden death during sleep.
    Tobé TJ; de Langen CD; Bink-Boelkens MT; Mook PH; Viersma JW; Lie KI; Wesseling H
    J Am Coll Cardiol; 1992 Mar; 19(3):541-9. PubMed ID: 1538007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiotoxicity reduction induced by halofantrine entrapped in nanocapsule devices.
    Leite EA; Grabe-Guimarães A; Guimarães HN; Machado-Coelho GL; Barratt G; Mosqueira VC
    Life Sci; 2007 Mar; 80(14):1327-34. PubMed ID: 17303179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal sinus bradycardia and the long QT syndrome.
    Beinder E; Grancay T; Menéndez T; Singer H; Hofbeck M
    Am J Obstet Gynecol; 2001 Sep; 185(3):743-7. PubMed ID: 11568808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced torsades de pointes in patients aged 80 years or more.
    Paran Y; Mashav N; Henis O; Swartzon M; Arbel Y; Justo D
    Anadolu Kardiyol Derg; 2008 Aug; 8(4):260-5. PubMed ID: 18676301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributing factors to the apparent clearance of bepridil in patients with paroxysmal or persistent atrial fibrillation: analysis using population pharmacokinetics.
    Shiga T; Hashiguchi M; Naganuma M; Suzuki A; Hagiwara N
    Ther Drug Monit; 2013 Jun; 35(3):367-73. PubMed ID: 23666576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Provocation of sudden heart rate oscillation with adenosine exposes abnormal QT responses in patients with long QT syndrome: a bedside test for diagnosing long QT syndrome.
    Viskin S; Rosso R; Rogowski O; Belhassen B; Levitas A; Wagshal A; Katz A; Fourey D; Zeltser D; Oliva A; Pollevick GD; Antzelevitch C; Rozovski U
    Eur Heart J; 2006 Feb; 27(4):469-75. PubMed ID: 16105845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QT interval variability and adaptation to heart rate changes in patients with long QT syndrome.
    Nemec J; Buncová M; Shusterman V; Winter B; Shen WK; Ackerman MJ
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):72-81. PubMed ID: 19140916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autonomic tone attenuates drug-induced QT prolongation.
    Smith AH; Norris KJ; Roden DM; Kannankeril PJ
    J Cardiovasc Electrophysiol; 2007 Sep; 18(9):960-4. PubMed ID: 17666066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beat-to-beat variability of repolarization differentiates the extent of torsadogenic potential of multi ion channel-blockers bepridil and amiodarone.
    Takahara A; Nakamura Y; Sugiyama A
    Eur J Pharmacol; 2008 Oct; 596(1-3):127-31. PubMed ID: 18786527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked sinus bradycardia and QT prolongation in a diabetic patient with severe hypoglycemia.
    Bolognesi R; Tsialtas D; Bolognesi MG; Giumelli C
    J Diabetes Complications; 2011; 25(5):349-51. PubMed ID: 21429766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of bepridil and CERM 4205 (ORG 30701) on the relation between cardiac cycle length and QT duration in healthy volunteers.
    Lecocq B; Lecocq V; Prost PL; Fleurot O; Boisson P; Jaillon P
    Am J Cardiol; 1990 Sep; 66(5):636-41. PubMed ID: 2203243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.